BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: MacLean C, Moenning U, Reichel A, Fricker G. Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats. Drug Metab Dispos. 2008;36:1249-1254. [PMID: 18378562 DOI: 10.1124/dmd.108.020859] [Cited by in Crossref: 113] [Cited by in F6Publishing: 118] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Connor KL, Bloise E, Desantis TZ, Lye SJ. Adaptation of the gut holobiont to malnutrition during mouse pregnancy depends on the type of nutritional adversity. The Journal of Nutritional Biochemistry 2023;111:109172. [DOI: 10.1016/j.jnutbio.2022.109172] [Reference Citation Analysis]
2 Naseem A, Pal A, Gowan S, Asad Y, Donovan A, Temesszentandrási-ambrus C, Kis E, Gaborik Z, Bhalay G, Raynaud F. Intracellular Metabolomics Identifies Efflux Transporter Inhibitors in a Routine Caco-2 Cell Permeability Assay—Biological Implications. Cells 2022;11:3286. [DOI: 10.3390/cells11203286] [Reference Citation Analysis]
3 Madla CM, Qin Y, Gavins FKH, Liu J, Dou L, Orlu M, Murdan S, Mai Y, Basit AW. Sex Differences in Intestinal P-Glycoprotein Expression in Wistar versus Sprague Dawley Rats. Pharmaceutics 2022;14:1030. [DOI: 10.3390/pharmaceutics14051030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ménochet K, Chanteux H, Henshall J, Nicolas J, Wright S, Asperen J, Ungell A. Intestinal Epithelium and Drug Transporters. Oral Drug Delivery for Modified Release Formulations 2022. [DOI: 10.1002/9781119772729.ch3] [Reference Citation Analysis]
5 Yin H, Shao H, Liu J, Qin Y, Deng W. Sex-specific and concentration-dependent influence of Cremophor RH 40 on ampicillin absorption via its effect on intestinal membrane transporters in rats. PLoS One 2022;17:e0263692. [PMID: 35226682 DOI: 10.1371/journal.pone.0263692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ding C, Li Y, Li X, Meng L, Fu R, Wang X, Li Y, Ma Y, Dong Z. QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats. Pharm Biol 2022;60:185-94. [PMID: 35001796 DOI: 10.1080/13880209.2021.2021949] [Reference Citation Analysis]
7 Zhang Q, Ni Y, Wang S, Agbana YL, Han Q, Liu W, Bai H, Yi Z, Yi X, Zhu Y, Sai B, Yang L, Shi Q, Kuang Y, Yang Z, Zhu Y. G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression. Int J Med Sci 2022;19:47-64. [PMID: 34975298 DOI: 10.7150/ijms.58902] [Reference Citation Analysis]
8 Koehn LM. ABC Transporters: Individual-Specific Considerations. The ADME Encyclopedia 2022. [DOI: 10.1007/978-3-030-84860-6_81] [Reference Citation Analysis]
9 Oh JH, Kim D, Lee H, Kim G, Park T, Kim MC, Lee YJ. Negligible Effect of Quercetin in the Pharmacokinetics of Sulfasalazine in Rats and Beagles: Metabolic Inactivation of the Interaction Potential of Quercetin with BCRP. Pharmaceutics 2021;13:1989. [PMID: 34959273 DOI: 10.3390/pharmaceutics13121989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Connor KL, Bloise E, Desantis TZ, Lye SJ. Adaptation of the gut holobiont to malnutrition during mouse pregnancy depends on the type of nutritional adversity.. [DOI: 10.1101/2021.10.26.465755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mai Y, Gavins FKH, Dou L, Liu J, Taherali F, Alkahtani ME, Murdan S, Basit AW, Orlu M. A Non-Nutritive Feeding Intervention Alters the Expression of Efflux Transporters in the Gastrointestinal Tract. Pharmaceutics 2021;13:1789. [PMID: 34834204 DOI: 10.3390/pharmaceutics13111789] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Liu W, Wei L, Kanai Y, He X. Studies on the Incompatibility between Bulbus fritillariae and Radix aconiti praeparata Based on the P-gp. Evid Based Complement Alternat Med 2021;2021:8351717. [PMID: 34650616 DOI: 10.1155/2021/8351717] [Reference Citation Analysis]
13 Kukal S, Guin D, Rawat C, Bora S, Mishra MK, Sharma P, Paul PR, Kanojia N, Grewal GK, Kukreti S, Saso L, Kukreti R. Multidrug efflux transporter ABCG2: expression and regulation. Cell Mol Life Sci 2021;78:6887-939. [PMID: 34586444 DOI: 10.1007/s00018-021-03901-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhang Y, Huang S, Zhong W, Chen W, Yao B, Wang X. 3D organoids derived from the small intestine: An emerging tool for drug transport research. Acta Pharm Sin B 2021;11:1697-707. [PMID: 34386316 DOI: 10.1016/j.apsb.2020.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Zhang D, Wei C, Hop CECA, Wright MR, Hu M, Lai Y, Khojasteh SC, Humphreys WG. Intestinal Excretion, Intestinal Recirculation, and Renal Tubule Reabsorption Are Underappreciated Mechanisms That Drive the Distribution and Pharmacokinetic Behavior of Small Molecule Drugs. J Med Chem 2021;64:7045-59. [PMID: 34010555 DOI: 10.1021/acs.jmedchem.0c01720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Kim JK, Choi MS, Kim JY, Yu JS, Seo JI, Yoo HH, Kim DH. Ginkgo biloba leaf extract suppresses intestinal human breast cancer resistance protein expression in mice: Correlation with gut microbiota. Biomed Pharmacother 2021;140:111712. [PMID: 34010745 DOI: 10.1016/j.biopha.2021.111712] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
17 Mai Y, Dou L, Yao Z, Madla CM, Gavins FKH, Taherali F, Yin H, Orlu M, Murdan S, Basit AW. Quantification of P-Glycoprotein in the Gastrointestinal Tract of Humans and Rodents: Methodology, Gut Region, Sex, and Species Matter. Mol Pharm 2021;18:1895-904. [PMID: 33886332 DOI: 10.1021/acs.molpharmaceut.0c00574] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
18 Koehn LM. ABC Transporters: Individual-Specific Considerations. The ADME Encyclopedia 2021. [DOI: 10.1007/978-3-030-51519-5_81-1] [Reference Citation Analysis]
19 Pala Kara Z, Ozturk Civelek D, Ozturk N, Okyar A. The effects of P-glycoprotein inhibitor zosuquidar on the sex and time-dependent pharmacokinetics of parenterally administered talinolol in mice. European Journal of Pharmaceutical Sciences 2021;156:105589. [DOI: 10.1016/j.ejps.2020.105589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Roncato R, Angelini J, Pani A, Cecchin E, Sartore-Bianchi A, Siena S, De Mattia E, Scaglione F, Toffoli G. CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions. Int J Mol Sci 2020;21:E6350. [PMID: 32883002 DOI: 10.3390/ijms21176350] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
21 Mai Y, Ashiru-oredope DA, Yao Z, Dou L, Madla CM, Taherali F, Murdan S, Basit AW. Boosting drug bioavailability in men but not women through the action of an excipient. International Journal of Pharmaceutics 2020;587:119678. [DOI: 10.1016/j.ijpharm.2020.119678] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
22 Binnefeld M, Fritz S, Balzer V, Skalická V, Witzigmann D, Kauczor HU, Fricker G, Salomon JJ. Physicochemical and biopharmaceutical characterization of novel Matrix-Liposomes. Eur J Pharm Biopharm 2020;153:158-67. [PMID: 32522680 DOI: 10.1016/j.ejpb.2020.06.001] [Reference Citation Analysis]
23 Dou L, Gavins FKH, Mai Y, Madla CM, Taherali F, Orlu M, Murdan S, Basit AW. Effect of Food and an Animal's Sex on P-Glycoprotein Expression and Luminal Fluids in the Gastrointestinal Tract of Wistar Rats. Pharmaceutics 2020;12:E296. [PMID: 32218182 DOI: 10.3390/pharmaceutics12040296] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
24 Markovic M, Zur M, Fine-Shamir N, Haimov E, González-Álvarez I, Dahan A. Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product Development. Pharmaceutics 2020;12:E295. [PMID: 32214015 DOI: 10.3390/pharmaceutics12030295] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
25 Morimoto C, Tamura Y, Asakawa S, Kuribayashi-Okuma E, Nemoto Y, Li J, Murase T, Nakamura T, Hosoyamada M, Uchida S, Shibata S. ABCG2 expression and uric acid metabolism of the intestine in hyperuricemia model rat. Nucleosides Nucleotides Nucleic Acids 2020;39:744-59. [PMID: 31983315 DOI: 10.1080/15257770.2019.1694684] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
26 Diehl HP, Wildey A, Prasasty VD, Siahaan TJ. Organization of the intestinal mucosa and barriers to oral drug delivery. Nanotechnology for Oral Drug Delivery. Elsevier; 2020. pp. 7-25. [DOI: 10.1016/b978-0-12-818038-9.00002-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Liang X, Staiger KM, Riddle E, Hao J, Lai Y. Role of transporters in drug disposition and drug-drug interactions. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters 2020. [DOI: 10.1016/b978-0-12-820018-6.00010-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Martinec O, Huliciak M, Staud F, Cecka F, Vokral I, Cerveny L. Anti-HIV and Anti-Hepatitis C Virus Drugs Inhibit P-Glycoprotein Efflux Activity in Caco-2 Cells and Precision-Cut Rat and Human Intestinal Slices. Antimicrob Agents Chemother 2019;63:e00910-19. [PMID: 31481446 DOI: 10.1128/AAC.00910-19] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
29 Shekhawat P, Pokharkar V. Risk assessment and QbD based optimization of an Eprosartan mesylate nanosuspension: In-vitro characterization, PAMPA and in-vivo assessment. Int J Pharm 2019;567:118415. [PMID: 31175989 DOI: 10.1016/j.ijpharm.2019.06.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
30 Mai Y, Dou L, Madla CM, Murdan S, Basit AW. Sex-Dependence in the Effect of Pharmaceutical Excipients: Polyoxyethylated Solubilising Excipients Increase Oral Drug Bioavailability in Male but not Female Rats. Pharmaceutics 2019;11:E228. [PMID: 31083453 DOI: 10.3390/pharmaceutics11050228] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
31 Azran C, Porat D, Fine-shamir N, Hanhan N, Dahan A. Oral levothyroxine therapy postbariatric surgery: Biopharmaceutical aspects and clinical effects. Surgery for Obesity and Related Diseases 2019;15:333-41. [DOI: 10.1016/j.soard.2019.01.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
32 Villa A, Klein B, Janssen B, Pedragosa J, Pepe G, Zinnhardt B, Vugts DJ, Gelosa P, Sironi L, Beaino W, Damont A, Dollé F, Jego B, Winkeler A, Ory D, Solin O, Vercouillie J, Funke U, Laner-Plamberger S, Blomster LV, Christophersen P, Vegeto E, Aigner L, Jacobs A, Planas AM, Maggi A, Windhorst AD. Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state. Theranostics 2018;8:5400-18. [PMID: 30555554 DOI: 10.7150/thno.25572] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 7.8] [Reference Citation Analysis]
33 Ashmawy SM, El-Gizawy SA, El Maghraby GM, Osman MA. Regional difference in intestinal drug absorption as a measure for the potential effect of P-glycoprotein efflux transporters. J Pharm Pharmacol 2019;71:362-70. [PMID: 30362574 DOI: 10.1111/jphp.13036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
34 Dou L, Mai Y, Madla CM, Orlu M, Basit AW. P-glycoprotein expression in the gastrointestinal tract of male and female rats is influenced differently by food. European Journal of Pharmaceutical Sciences 2018;123:569-75. [DOI: 10.1016/j.ejps.2018.08.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
35 Margier M, Collet X, le May C, Desmarchelier C, André F, Lebrun C, Defoort C, Bluteau A, Borel P, Lespine A, Reboul E. ABCB1 (P-glycoprotein) regulates vitamin D absorption and contributes to its transintestinal efflux. FASEB J 2019;33:2084-94. [PMID: 30222077 DOI: 10.1096/fj.201800956R] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
36 George DM, Huntley RJ, Cusack K, Duignan DB, Hoemann M, Loud J, Mario R, Melim T, Mullen K, Somal G, Wang L, Edmunds JJ. Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitors. PLoS One 2018;13:e0203567. [PMID: 30192846 DOI: 10.1371/journal.pone.0203567] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
37 Beig A, Markovic M, Dahan A. Solubility, Permeability, and Their Interplay. Early Drug Development 2018. [DOI: 10.1002/9783527801756.ch8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
38 Wolk O, Markovic M, Porat D, Fine-Shamir N, Zur M, Beig A, Dahan A. Segmental-Dependent Intestinal Drug Permeability: Development and Model Validation of In Silico Predictions Guided by In Vivo Permeability Values. J Pharm Sci 2019;108:316-25. [PMID: 30055228 DOI: 10.1016/j.xphs.2018.07.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
39 Aboulfotouh K, Allam AA, El-badry M, El-sayed AM. Self-emulsifying drug–delivery systems modulate P-glycoprotein activity: role of excipients and formulation aspects. Nanomedicine 2018;13:1813-34. [DOI: 10.2217/nnm-2017-0354] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
40 Mai Y, Dou L, Murdan S, Basit AW. An animal's sex influences the effects of the excipient PEG 400 on the intestinal P-gp protein and mRNA levels, which has implications for oral drug absorption. Eur J Pharm Sci 2018;120:53-60. [PMID: 29678614 DOI: 10.1016/j.ejps.2018.04.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
41 Afonso-pereira F, Dou L, Trenfield SJ, Madla CM, Murdan S, Sousa J, Veiga F, Basit AW. Sex differences in the gastrointestinal tract of rats and the implications for oral drug delivery. European Journal of Pharmaceutical Sciences 2018;115:339-44. [DOI: 10.1016/j.ejps.2018.01.043] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
42 Chen L, Zhou L, Huang J, Wang Y, Yang G, Tan Z, Wang Y, Zhou G, Liao J, Ouyang D. Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers. Front Pharmacol 2017;8:965. [PMID: 29375375 DOI: 10.3389/fphar.2017.00965] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
43 Böhmdorfer M, Szakmary A, Schiestl RH, Vaquero J, Riha J, Brenner S, Thalhammer T, Szekeres T, Jäger W. Involvement of UDP-Glucuronosyltransferases and Sulfotransferases in the Excretion and Tissue Distribution of Resveratrol in Mice. Nutrients 2017;9:E1347. [PMID: 29231856 DOI: 10.3390/nu9121347] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
44 Shchul’kin AV, Yakusheva EN, Chernykh IV, Nikiforov AA, Popova NP. Effects of Testosterone on the Functional Activity of P-Glycoprotein. Pharm Chem J 2017;51:743-7. [DOI: 10.1007/s11094-017-1685-1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
45 Porat D, Dahan A. Active intestinal drug absorption and the solubility-permeability interplay. Int J Pharm 2018;537:84-93. [PMID: 29102702 DOI: 10.1016/j.ijpharm.2017.10.058] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
46 Mai Y, Afonso-pereira F, Murdan S, Basit AW. Excipient-mediated alteration in drug bioavailability in the rat depends on the sex of the animal. European Journal of Pharmaceutical Sciences 2017;107:249-55. [DOI: 10.1016/j.ejps.2017.07.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
47 Gantner ME, Peroni RN, Morales JF, Villalba ML, Ruiz ME, Talevi A. Development and Validation of a Computational Model Ensemble for the Early Detection of BCRP/ABCG2 Substrates during the Drug Design Stage. J Chem Inf Model 2017;57:1868-80. [DOI: 10.1021/acs.jcim.7b00016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
48 Lin CH, Hsu KW, Chen CH, Uang YS, Lin CJ. Differential changes in the pharmacokinetics of statins in collagen-induced arthritis rats. Biochem Pharmacol 2017;142:216-28. [PMID: 28636885 DOI: 10.1016/j.bcp.2017.06.118] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
49 Li M, de Graaf IA, van de Steeg E, de Jager MH, Groothuis GM. The consequence of regional gradients of P-gp and CYP3A4 for drug-drug interactions by P-gp inhibitors and the P-gp/CYP3A4 interplay in the human intestine ex vivo. Toxicology in Vitro 2017;40:26-33. [DOI: 10.1016/j.tiv.2016.12.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
50 Cario E. P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers. World J Gastroenterol 2017; 23(9): 1513-1520 [PMID: 28321153 DOI: 10.3748/wjg.v23.i9.1513] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
51 Turkanovic J, Ward MB, Gerber JP, Milne RW. Effect of Garlic, Gingko, and St. John's Wort Extracts on the Pharmacokinetics of Fexofenadine: A Mechanistic Study. Drug Metab Dispos 2017;45:569-75. [PMID: 28188296 DOI: 10.1124/dmd.116.073528] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
52 Duan C, Guo JM, Dai Y, Xia YF. The absorption enhancement of norisoboldine in the duodenum of adjuvant-induced arthritis rats involves the impairment of P-glycoprotein. Biopharm Drug Dispos 2017;38:75-83. [PMID: 27925244 DOI: 10.1002/bdd.2053] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
53 Liu X, Zhu L, Huang B, Huang J, Cai Y, Zhu L, Wu B, Fu X, Zhang X, Rong Y, Xiao Q, Guo J, Li A, Guo Y, Yuan M. Poor and enantioselective bioavailability of naftopidil enantiomers is due to extensive and stereoselective metabolism in rat liver. Journal of Pharmaceutical and Biomedical Analysis 2017;132:165-72. [DOI: 10.1016/j.jpba.2016.09.038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
54 Li M, de Graaf IA, de Jager MH, Groothuis GM. P-gp activity and inhibition in the different regions of human intestine ex vivo: P-gp function in human intestinal regions. Biopharm Drug Dispos 2017;38:127-38. [DOI: 10.1002/bdd.2047] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
55 Arana MR, Tocchetti GN, Rigalli JP, Mottino AD, Villanueva SS. Physiological and pathophysiological factors affecting the expression and activity of the drug transporter MRP2 in intestine. Impact on its function as membrane barrier. Pharmacological Research 2016;109:32-44. [DOI: 10.1016/j.phrs.2016.04.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
56 Pan G, Li T, Zeng Q, Wang X, Zhu Y. Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux. Molecules 2016;21:E183. [PMID: 26861264 DOI: 10.3390/molecules21020183] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
57 Li M, de Graaf IAM, Groothuis GMM. Precision-cut intestinal slices: alternative model for drug transport, metabolism, and toxicology research. Expert Opinion on Drug Metabolism & Toxicology 2016;12:175-90. [DOI: 10.1517/17425255.2016.1125882] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
58 Couyoupetrou M, Di Ianni M, Gantner M, Pesce G, Peroni R, Talevi A, Bruno-blanch LE. Discovering New Antiepileptic Drugs Addressing the Transporter Hypothesis of Refractory Epilepsy: Ligand-Based Approximations. Methods in Pharmacology and Toxicology 2016. [DOI: 10.1007/978-1-4939-6355-3_14] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
59 Yang X, Wang C, Zhou P, Yu J, Asenso J, Ma Y, Wei W. Absorption characteristic of paeoniflorin-6′-O-benzene sulfonate (CP-25) in in situ single-pass intestinal perfusion in rats. Xenobiotica 2016;46:775-83. [DOI: 10.3109/00498254.2015.1121553] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
60 Li M, de Graaf IA, de Jager MH, Groothuis GM. Rat precision-cut intestinal slices to study P-gp activity and the potency of its inhibitors ex vivo. Toxicology in Vitro 2015;29:1070-8. [DOI: 10.1016/j.tiv.2015.04.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
61 Zeng XY, Dong S, He NN, Jiang CJ, Dai Y, Xia YF. Comparative pharmacokinetics of arctigenin in normal and type 2 diabetic rats after oral and intravenous administration. Fitoterapia 2015;105:119-26. [PMID: 26102179 DOI: 10.1016/j.fitote.2015.06.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
62 Singh Badhan RK. Physiologically Based Pharmacokinetic Modelling in Drug Delivery. Computational Pharmaceutics 2015. [DOI: 10.1002/9781118573983.ch13] [Reference Citation Analysis]
63 Laksitorini M, Prasasty VD, Kiptoo PK, Siahaan TJ. Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers. Ther Deliv 2014;5:1143-63. [PMID: 25418271 DOI: 10.4155/tde.14.67] [Cited by in Crossref: 69] [Cited by in F6Publishing: 76] [Article Influence: 9.9] [Reference Citation Analysis]
64 Kawase A, Araki Y, Ueda Y, Nakazaki S, Iwaki M. Impact of a high-cholesterol diet on expression levels of Niemann–Pick C1-like 1 and intestinal transporters in rats and mice. Eur J Drug Metab Pharmacokinet 2016;41:457-63. [DOI: 10.1007/s13318-015-0269-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
65 Nicken P, Willenberg I, Keutz Av, Elsner Lv, Hamscher G, Vanhaecke L, Schröder B, Breves G, Schebb NH, Steinberg P. Intestinal absorption and cell transforming potential of PhIP-M1, a bacterial metabolite of the heterocyclic aromatic amine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Toxicol Lett 2015;234:92-8. [PMID: 25707896 DOI: 10.1016/j.toxlet.2015.02.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
66 Lozoya-Agullo I, Zur M, Wolk O, Beig A, González-Álvarez I, González-Álvarez M, Merino-Sanjuán M, Bermejo M, Dahan A. In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluisio experimental approaches. Int J Pharm 2015;480:1-7. [PMID: 25595387 DOI: 10.1016/j.ijpharm.2015.01.014] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 7.9] [Reference Citation Analysis]
67 Lee CA, O’connor MA, Ritchie TK, Galetin A, Cook JA, Ragueneau-majlessi I, Ellens H, Feng B, Taub ME, Paine MF, Polli JW, Ware JA, Zamek-gliszczynski MJ. Breast Cancer Resistance Protein (ABCG2) in Clinical Pharmacokinetics and Drug Interactions: Practical Recommendations for Clinical Victim and Perpetrator Drug-Drug Interaction Study Design. Drug Metab Dispos 2015;43:490-509. [DOI: 10.1124/dmd.114.062174] [Cited by in Crossref: 91] [Cited by in F6Publishing: 96] [Article Influence: 13.0] [Reference Citation Analysis]
68 Stappaerts J, Brouwers J, Annaert P, Augustijns P. In situ perfusion in rodents to explore intestinal drug absorption: challenges and opportunities. Int J Pharm 2015;478:665-81. [PMID: 25448559 DOI: 10.1016/j.ijpharm.2014.11.035] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
69 Ji H, Tang J, Li M, Ren J, Zheng N, Wu L. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin. Drug Deliv 2016;23:459-70. [PMID: 24892628 DOI: 10.3109/10717544.2014.918677] [Cited by in Crossref: 99] [Cited by in F6Publishing: 107] [Article Influence: 12.4] [Reference Citation Analysis]
70 Zur M, Gasparini M, Wolk O, Amidon GL, Dahan A. The low/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalol. Mol Pharm 2014;11:1707-14. [PMID: 24735251 DOI: 10.1021/mp500152y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 6.3] [Reference Citation Analysis]
71 Zakeri-milani P, Valizadeh H. Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions. Expert Opinion on Drug Metabolism & Toxicology 2014;10:859-71. [DOI: 10.1517/17425255.2014.905543] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
72 Jiang C, He X, Yang X, Zhang S, Li H, Song Z, Zhang C, Yang Z, Li P. Intestinal Absorptive Transport of Genkwanin from Flos genkwa Using a Single-Pass Intestinal Perfusion Rat Model. Am J Chin Med 2014;42:349-59. [DOI: 10.1142/s0192415x14500232] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
73 Kis O, Walmsley SL, Bendayan R. In Vitro and In Situ Evaluation of pH-Dependence of Atazanavir Intestinal Permeability and Interactions with Acid-Reducing Agents. Pharm Res 2014;31:2404-19. [DOI: 10.1007/s11095-014-1336-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
74 Cressman AM, Petrovic V, Piquette-miller M. Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response. Expert Review of Clinical Pharmacology 2014;5:69-89. [DOI: 10.1586/ecp.11.66] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 8.5] [Reference Citation Analysis]
75 Wolk O, Dahan A. Segmental-Dependent Drug Absorption and Delivery: The Intestinal Tract. Advances in Delivery Science and Technology 2014. [DOI: 10.1007/978-1-4614-9434-8_16] [Reference Citation Analysis]
76 Stappaerts J, Fattah S, Annaert P, Augustijns P. Hepatobiliary and intestinal elimination of darunavir in an integrated preclinical rat model. Xenobiotica 2013;44:489-97. [DOI: 10.3109/00498254.2013.861541] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
77 Liu W, Kulkarni K, Hu M. Gender-dependent differences in uridine 5'-diphospho-glucuronosyltransferase have implications in metabolism and clearance of xenobiotics. Expert Opinion on Drug Metabolism & Toxicology 2013;9:1555-69. [DOI: 10.1517/17425255.2013.829040] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
78 Oswald S, Gröer C, Drozdzik M, Siegmund W. Mass spectrometry-based targeted proteomics as a tool to elucidate the expression and function of intestinal drug transporters. AAPS J 2013;15:1128-40. [PMID: 23982336 DOI: 10.1208/s12248-013-9521-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
79 Oswald S, Gröer C, Drozdzik M, Siegmund W. Mass spectrometry-based targeted proteomics as a tool to elucidate the expression and function of intestinal drug transporters. AAPS J 2013;15:1128-40. [PMID: 23982336 DOI: 10.1208/s12248-013-9521-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
80 Stappaerts J, Annaert P, Augustijns P. Site dependent intestinal absorption of darunavir and its interaction with ketoconazole. European Journal of Pharmaceutical Sciences 2013;49:51-6. [DOI: 10.1016/j.ejps.2013.01.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
81 White MP, Babayeva M, Taft DR, Maniar M. Determination of intestinal permeability of rigosertib (ON 01910.Na, Estybon): correlation with systemic exposure. Journal of Pharmacy and Pharmacology 2013;65:960-9. [DOI: 10.1111/jphp.12057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
82 Duan L, Yan Y, Sun Y, Zhao B, Hu W, Li G. Contribution of TRPV1 and multidrug resistance proteins in the permeation of capsaicin across different intestinal regions. Int J Pharm 2013;445:134-40. [PMID: 23402980 DOI: 10.1016/j.ijpharm.2013.02.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
83 Zhang D, Frost CE, He K, Rodrigues AD, Wang X, Wang L, Goosen TC, Humphreys WG. Investigating the Enteroenteric Recirculation of Apixaban, a Factor Xa Inhibitor: Administration of Activated Charcoal to Bile Duct-Cannulated Rats and Dogs Receiving an Intravenous Dose and Use of Drug Transporter Knockout Rats. Drug Metab Dispos 2013;41:906-15. [DOI: 10.1124/dmd.112.050575] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
84 Rong Z, Xu Y, Zhang C, Xiang D, Li X, Liu D. Evaluation of intestinal absorption of amtolmetin guacyl in rats: Breast cancer resistant protein as a primary barrier of oral bioavailability. Life Sciences 2013;92:245-51. [DOI: 10.1016/j.lfs.2012.12.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
85 Nicken P, Schröder B, von Keutz A, Breves G, Steinberg P. The colon carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is actively secreted in the distal colon of the rat: an integrated view on the role of PhIP transport and metabolism in PhIP-induced colon carcinogenesis. Arch Toxicol 2013;87:895-904. [DOI: 10.1007/s00204-012-1006-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
86 Kis O, Zastre JA, Hoque MT, Walmsley SL, Bendayan R. Role of Drug Efflux and Uptake Transporters in Atazanavir Intestinal Permeability and Drug-Drug Interactions. Pharm Res 2013;30:1050-64. [DOI: 10.1007/s11095-012-0942-y] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 5.1] [Reference Citation Analysis]
87 Jin H, Song B, Kim S, Shim W, Kim D, Chong S, Chung S, Shim C. Transport of gemifloxacin, a 4th generation quinolone antibiotic, in the Caco-2 and engineered MDCKII cells, and potential involvement of efflux transporters in the intestinal absorption of the drug. Xenobiotica 2012;43:355-67. [DOI: 10.3109/00498254.2012.720740] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
88 Planas JM, Alfaras I, Colom H, Juan ME. The bioavailability and distribution of trans-resveratrol are constrained by ABC transporters. Arch Biochem Biophys 2012;527:67-73. [PMID: 22750234 DOI: 10.1016/j.abb.2012.06.004] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 8.2] [Reference Citation Analysis]
89 Okyar A, Dressler C, Hanafy A, Baktir G, Lemmer B, Spahn-langguth H. Circadian Variations in Exsorptive Transport: In Situ Intestinal Perfusion Data and In Vivo Relevance. Chronobiology International 2012;29:443-53. [DOI: 10.3109/07420528.2012.668996] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
90 Tucker TG, Milne AM, Fournel-gigleux S, Fenner KS, Coughtrie MW. Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 2 in human liver and duodenum. Biochemical Pharmacology 2012;83:279-85. [DOI: 10.1016/j.bcp.2011.10.017] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
91 Adane ED, Liu Z, Xiang TX, Anderson BD, Leggas M. Pharmacokinetic modeling to assess factors affecting the oral bioavailability of the lactone and carboxylate forms of the lipophilic camptothecin analogue AR-67 in rats. Pharm Res 2012;29:1722-36. [PMID: 22068278 DOI: 10.1007/s11095-011-0617-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
92 Peroni RN, Di Gennaro SS, Hocht C, Chiappetta DA, Rubio MC, Sosnik A, Bramuglia GF. Efavirenz is a substrate and in turn modulates the expression of the efflux transporter ABCG2/BCRP in the gastrointestinal tract of the rat. Biochemical Pharmacology 2011;82:1227-33. [DOI: 10.1016/j.bcp.2011.07.081] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
93 Haslam IS, Wright JA, O'Reilly DA, Sherlock DJ, Coleman T, Simmons NL. Intestinal ciprofloxacin efflux: the role of breast cancer resistance protein (ABCG2). Drug Metab Dispos 2011;39:2321-8. [PMID: 21930826 DOI: 10.1124/dmd.111.038323] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 3.7] [Reference Citation Analysis]
94 Azorín-Ortuño M, Yáñez-Gascón MJ, Vallejo F, Pallarés FJ, Larrosa M, Lucas R, Morales JC, Tomás-Barberán FA, García-Conesa MT, Espín JC. Metabolites and tissue distribution of resveratrol in the pig. Mol Nutr Food Res. 2011;55:1154-1168. [PMID: 21710561 DOI: 10.1002/mnfr.201100140] [Cited by in Crossref: 108] [Cited by in F6Publishing: 110] [Article Influence: 9.8] [Reference Citation Analysis]
95 Quevedo MA, Nieto LE, Briñón MC. P-glycoprotein limits the absorption of the anti-HIV drug zidovudine through rat intestinal segments. European Journal of Pharmaceutical Sciences 2011;43:151-9. [DOI: 10.1016/j.ejps.2011.04.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
96 Tydén E, Bjornstrom H, Tjälve H, Larsson P. Expression and localization of BCRP, MRP1 and MRP2 in intestines, liver and kidney in horse. J Vet Pharmacol Ther 2010;33:332-40. [PMID: 20646193 DOI: 10.1111/j.1365-2885.2009.01140.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
97 Dahan A, Tsume Y, Sun J, Miller JM, Amidon GL. Oral Bioavailability of Peptide and Peptidomimetic Drugs. In: Hughes AB, editor. Amino Acids, Peptides and Proteins in Organic Chemistry. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2011. pp. 277-92. [DOI: 10.1002/9783527631827.ch8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
98 Mariana B, Adrián L, Guillermo V, Juan S, Laura M, Carlos L. Gender-related differences on P-glycoprotein-mediated drug intestinal transport in rats. Journal of Pharmacy and Pharmacology 2011;63:619-26. [DOI: 10.1111/j.2042-7158.2010.01230.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
99 Maclean C, Moenning U, Reichel A, Fricker G. Regional absorption of fexofenadine in rat intestine. European Journal of Pharmaceutical Sciences 2010;41:670-4. [DOI: 10.1016/j.ejps.2010.09.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
100 Graber-maier A, Gutmann H, Drewe J. A New Intestinal Cell Culture Model To Discriminate the Relative Contribution of P-gp and BCRP on Transport of Substrates Such as Imatinib. Mol Pharmaceutics 2010;7:1618-28. [DOI: 10.1021/mp100040f] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
101 Giraud C, Manceau S, Treluyer JM. ABC transporters in human lymphocytes: expression, activity and role, modulating factors and consequences for antiretroviral therapies. Expert Opin Drug Metab Toxicol 2010;6:571-89. [PMID: 20367109 DOI: 10.1517/17425251003601953] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
102 Draheim V, Reichel A, Weitschies W, Moenning U. N-glycosylation of ABC transporters is associated with functional activity in sandwich-cultured rat hepatocytes. Eur J Pharm Sci 2010;41:201-9. [PMID: 20558284 DOI: 10.1016/j.ejps.2010.06.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
103 Nicken P, Hamscher G, Breves G, Steinberg P. Uptake of the colon carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by different segments of the rat gastrointestinal tract: Its implication in colorectal carcinogenesis. Toxicology Letters 2010;196:60-6. [DOI: 10.1016/j.toxlet.2010.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
104 Lechner C, Reichel V, Moenning U, Reichel A, Fricker G. Development of a fluorescence-based assay for drug interactions with human Multidrug Resistance Related Protein (MRP2; ABCC2) in MDCKII-MRP2 membrane vesicles. European Journal of Pharmaceutics and Biopharmaceutics 2010;75:284-90. [DOI: 10.1016/j.ejpb.2010.03.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
105 Lowes S, Haslam IS, Fihn BM, Hilgendorf C, Karlsson JE, Simmons NL, Ungell AL. The Effects of Pregnenolone 16α-Carbonitrile Dosing on Digoxin Pharmacokinetics and Intestinal Absorption in the Rat. Pharmaceutics 2010;2:61-77. [PMID: 27721343 DOI: 10.3390/pharmaceutics2010061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
106 Zvonar A, Berginc K, Kristl A, Gašperlin M. Microencapsulation of self-microemulsifying system: Improving solubility and permeability of furosemide. International Journal of Pharmaceutics 2010;388:151-8. [DOI: 10.1016/j.ijpharm.2009.12.055] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
107 Berginc K, Žakelj S, Kristl A. In vitro interactions between aged garlic extract and drugs used for the treatment of cardiovascular and diabetic patients. Eur J Nutr 2010;49:373-84. [DOI: 10.1007/s00394-010-0095-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
108 Juan ME, González-pons E, Planas JM. Multidrug Resistance Proteins Restrain the Intestinal Absorption of trans-Resveratrol in Rats. The Journal of Nutrition 2010;140:489-95. [DOI: 10.3945/jn.109.114959] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 5.0] [Reference Citation Analysis]
109 Kiki-Mvouaka S, Ménez C, Borin C, Lyazrhi F, Foucaud-Vignault M, Dupuy J, Collet X, Alvinerie M, Lespine A. Role of P-glycoprotein in the disposition of macrocyclic lactones: A comparison between ivermectin, eprinomectin, and moxidectin in mice. Drug Metab Dispos 2010;38:573-80. [PMID: 20089736 DOI: 10.1124/dmd.109.030700] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 4.1] [Reference Citation Analysis]
110 Keldenich J. Measurement and Prediction of Oral Absorption. C&B 2009;6:2000-13. [DOI: 10.1002/cbdv.200900054] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
111 van Waarde A, Ramakrishnan NK, Rybczynska AA, Elsinga PH, Berardi F, de Jong JR, Kwizera C, Perrone R, Cantore M, Sijbesma JW, Dierckx RA, Colabufo NA. Synthesis and preclinical evaluation of novel PET probes for P-glycoprotein function and expression. J Med Chem 2009;52:4524-32. [PMID: 19530699 DOI: 10.1021/jm900485a] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
112 Dahan A, Amidon GL. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting. Am J Physiol Gastrointest Liver Physiol 2009;297:G371-7. [PMID: 19541926 DOI: 10.1152/ajpgi.00102.2009] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 6.2] [Reference Citation Analysis]
113 Dahan A, Sabit H, Amidon GL. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine. Drug Metab Dispos 2009;37:2028-36. [PMID: 19589874 DOI: 10.1124/dmd.109.028282] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 6.1] [Reference Citation Analysis]
114 Kendall RA, Alhnan MA, Nilkumhang S, Murdan S, Basit AW. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery. European Journal of Pharmaceutical Sciences 2009;37:284-90. [DOI: 10.1016/j.ejps.2009.02.015] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
115 Uno S, Uraki M, Ito A, Shinozaki Y, Yamada A, Kawase A, Iwaki M. Changes in mRNA expression of ABC and SLC transporters in liver and intestines of the adjuvant-induced arthritis rat. Biopharm Drug Dispos 2009;30:49-54. [PMID: 19152228 DOI: 10.1002/bdd.639] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]